In summary, we report that the anti-RA drug auranofin has a dual function, increasing hepcidin expression via the NF-κB/IL-6/STAT3 signaling pathway and—at high doses—inducing ferroptosis by inhibiting the thioredoxin system (Supplementary Fig. S6). The gene discussed is STAT3; the disease is rheumatoid arthritis.